Can Salesforce Stock Recover? Here's What Wall Street Thinks

Salesforce shares jumped about 4% to close near $248 after the company reported a better-than-expected profit driven by demand for its AI offerings and raised its outlook, marking the stock's highest close in roughly a month despite being down nearly 30% year-to-date. Analysts are broadly bullish — Morgan Stanley reiterated an overweight rating with a $405 target, Jefferies kept a $375 buy target, and Bank of America cited faster-than-expected backlog growth and a $305 target — while Visible Alpha shows 14 of 18 analysts with buy calls and a mean target near $330, signaling potential upside if AI-related bookings continue to accelerate.

Analysis

Market structure: Salesforce (CRM) winning if enterprise AI adoption accelerates — beneficiaries include CRM, its ISV ecosystem, and cloud providers (AWS/Azure) who capture the compute bill; losers are pure-play data/AI names that lack embedded enterprise sales motions. Backlog expansion implies demand > supply for enterprise AI projects today; that supports pricing power on seat/features upsells and points to potential ARR re-acceleration over the next 2–8 quarters. Cross-asset: stronger CRM fundamentals should tighten its credit spreads and compress implied equity vol; a sustained rally would pressure high-multiple AI hardware names and lift software sector FX‑sensitive tech flows into USD-strengthening patterns.

Risk assessment: Tail risks include regulatory interventions on data usage or AI liability (20–30% probability over 12–36 months), execution risk in product integration causing churn, and cloud-cost inflation compressing margins if pass-through pricing fails. Immediate (days): earnings-driven volatility and options pinning; short-term (weeks/months): bookings/backlog and guide cadence; long-term (quarters/years): conversion of backlog to ARR and margin recovery. Hidden dependency: CRM’s AI ROI hinges on customers’ willingness to pay for higher cloud spend and third-party compute partners — monitor gross retention and cloud op-ex trends as second-order signals.

Trade implications: Favor asymmetric long exposure to CRM sized 2–3% of risk capital with built-in hedges; use calendar/vertical call spreads to cap premium outlay and exploit expected vol compression on positive data points (next 90–180 days). Consider a relative-value pair: long CRM vs short Snowflake (SNOW) to express enterprise SaaS resilience vs. pure-data valuation risk, sized dollar-neutral. Rotate portfolio modestly into enterprise SaaS and away from AI-infra/hardware names that already price full TAM; reduce positions in high-P/S peers where backlogs aren’t expanding.

Contrarian angles: Consensus (14/18 analysts bullish) may underweight conversion risk — backlog growth can be shallow if projects stall; the market may be underestimating the time to monetize AI (6–12+ months). Reaction is likely underdone on upside given CRM is ~30% YTD down; however, complacency on cloud-cost pass-through or a single high-profile AI failure could trigger >20% downside quickly. Historical parallel: enterprise software rebounds often lag tech rallies until 2–3 successive quarters of ARR beats confirm sustainable trends.

Key Decisions for Investors

• Establish a 2–3% net-long position in CRM now (buy at market near $248) with a tactical add-to-dip tranche if price falls to $230; set a protective stop-loss at $210 (≈15% haircut) and a 9–12 month target of $330 (analyst mean) for ~33% upside.
• Buy a cost-limited call spread to lever the bullish view: Dec 2026 CRM 270/360 call spread (size 0.5–1% notional) to capture upside while capping premium; if spreads compress after two positive quarters, monetize by rolling or selling into strength >25% gain.
• Implement a dollar-neutral pair trade: long CRM (1.5% notional) vs short SNOW (1.5% notional) to express conviction in enterprise AI monetization over pure-data valuation; unwind if CRM backlog growth <3% QoQ or SNOW reports >5% beat on cloud consumption (signals re-rating).
• Buy a 3–6 month tail hedge: CRM 10–12% OTM puts (size 0.5% portfolio) expiring within earnings cadence to protect against a >12% adverse move from execution/regulatory shock; reduce hedge if implied vol falls below historical 30-day realized vol by >5 percentage points.